| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|
| Period End Date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 |
|---|
| Sales | 1,515.91 | 1,356.51 | 1,257.37 | 1,150.98 | 1,074.75 | 963.88 | 994.85 | 882.75 | 727.85 | 603.84 |
| Total Revenues | 1,515.91 | 1,356.51 | 1,257.37 | 1,150.98 | 1,074.75 | 963.88 | 994.85 | 882.75 | 727.85 | 603.84 |
| Cost of sales | 777.64 | 713.18 | 673.49 | 631.88 | 589.42 | 562.70 | 562.49 | 487.98 | 401.60 | 338.81 |
| Gross Profit | 738.27 | 643.33 | 583.87 | 519.10 | 485.33 | 401.18 | 432.37 | 394.77 | 326.25 | 265.03 |
| Goodwill impairment charge | -- | -- | -- | -- | -- | -- | -- | 0.66 | -- | -- |
| Intangible asset impairment charge | -- | -- | -- | -- | -- | -- | 23.75 | -- | -- | -- |
| Research and development | 97.35 | 87.47 | 82.73 | 75.51 | 71.25 | 57.54 | 65.62 | 59.53 | 51.40 | 45.23 |
| Acquired in-process research and development | 0.00 | 0.00 | 1.55 | 6.67 | 0.00 | 0.25 | 0.53 | 0.64 | 12.14 | 0.46 |
| Selling, general and administrative | 455.21 | 399.73 | 373.68 | 342.53 | 335.69 | 297.72 | 327.27 | 276.02 | 229.13 | 184.40 |
| Legal settlement | -- | -- | 0.00 | 0.00 | (10.04) | (18.68) | -- | -- | -- | -- |
| Impairment | 0.00 | 0.00 | (0.27) | (2.22) | (4.28) | (36.50) | -- | -- | (0.81) | -- |
| Contingent consideration benefit | (0.98) | (0.44) | (1.70) | (4.61) | (3.16) | 7.96 | 0.23 | 0.70 | 0.30 | (0.06) |
| Total Operating Expenses | 553.55 | 487.64 | 459.93 | 431.54 | 424.42 | 402.74 | 416.93 | 336.15 | 293.18 | 230.15 |
| Operating Income (Loss) | 184.72 | 155.69 | 123.94 | 87.56 | 60.92 | (1.56) | 15.43 | 58.62 | 33.07 | 34.88 |
| Interest expense | 26.46 | 31.22 | 15.51 | 6.34 | 5.26 | 9.99 | 12.41 | 10.36 | 7.74 | 8.80 |
| Litigation settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | 15.07 | 26.23 | 2.46 | 0.44 | 0.77 | 0.60 | (0.29) | 1.20 | 0.38 | 0.08 |
| Other income (expense) | (2.39) | (0.71) | 1.20 | 0.97 | (2.51) | (2.28) | (0.54) | 0.06 | (0.87) | (0.77) |
| Bargain purchase gain | -- | -- | -- | -- | -- | -- | 0.00 | -- | 11.04 | -- |
| Total other Income (Expense) | (13.78) | (5.70) | (11.86) | (4.93) | (7.00) | (11.67) | (13.24) | (9.10) | 2.81 | (9.49) |
| Income (loss) before income taxes | 170.94 | 149.99 | 112.09 | 82.63 | 53.92 | (13.23) | 2.19 | 49.52 | 35.88 | 25.39 |
| Income tax expense (benefit) | 42.45 | 29.64 | 17.68 | 8.11 | 5.46 | (3.39) | (3.26) | 7.50 | 8.36 | 5.27 |
| Current tax expense: Foreign | 14.63 | 13.16 | 10.86 | 10.29 | 8.48 | 8.41 | 8.04 | -- | 5.17 | -- |
| Current tax expense: Federal | 17.75 | 26.06 | 15.68 | 9.58 | 0.81 | (0.94) | 0.48 | -- | 3.85 | -- |
| Current tax expense: State | 4.86 | 5.29 | 3.78 | 3.16 | 0.81 | 0.44 | 0.66 | -- | 0.65 | -- |
| Deferred (benefit) expense: Federal | 4.77 | (12.61) | (11.03) | (10.44) | (0.47) | (2.69) | (8.11) | -- | (0.31) | -- |
| Deferred (benefit) expense: State | 0.38 | (1.42) | (1.70) | (3.62) | (1.85) | (4.52) | (3.52) | -- | (0.22) | -- |
| Deferred (benefit) expense: Foreign | 0.07 | (0.84) | 0.09 | (0.87) | (2.32) | (4.08) | (0.80) | -- | (0.77) | -- |
| Net Income (loss) Available to Common Shareholders | 128.49 | 120.36 | 94.41 | 74.52 | 48.45 | (9.84) | 5.45 | 42.02 | 27.52 | 20.12 |
| Net Earnings Per Share (Basic) | 2.17 | 2.07 | 1.64 | 1.31 | 0.86 | (0.18) | 0.10 | 0.80 | 0.56 | 0.45 |
| Net Earnings Per Share (Diluted) | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 | (0.18) | 0.10 | 0.78 | 0.55 | 0.45 |
| Weighted Average Shares Outstanding (Basic) | 59.16 | 58.22 | 57.59 | 56.81 | 56.15 | 55.43 | 55.08 | 52.27 | 48.81 | 44.41 |
| Weighted Average Shares Outstanding (Diluted) | 60.46 | 59.37 | 58.36 | 57.67 | 57.36 | 55.43 | 56.24 | 53.93 | 50.10 | 44.86 |